Insiders · Profile

Johnson Philip L

EVP & Chief Financial Officer at Jazz Pharmaceuticals. Filing since 1 Mar 2024. CIK 0002013156

Company

Date

Role

Action

Amount

Of holding

1 Mar 2024

EVP & Chief Financial Officer

Bought

12,000

$1.44M

75.3%

1 decision on file.